1. MicroRNAs and their role in environmental chemical carcinogenesis.
    Minghui Li et al, 2019, Environ Geochem Health CrossRef
  2. Pharmacological activation of SIRT6 triggers lethal autophagy in human cancer cells
    Sara Iachettini et al, 2018, Cell Death Dis CrossRef
  3. MicroRNA-mediated redox regulation modulates therapy resistance in cancer cells: clinical perspectives
    Safieh Ebrahimi et al, 2019, Cell Oncol. CrossRef
  4. Transcriptional activation of SIRT6 via FKHRL1/FOXO3a inhibits the Warburg effect in glioblastoma cells
    Zhen Dong et al, 2019, Cellular Signalling CrossRef
  5. NAMPT as a Dedifferentiation-Inducer Gene: NAD+ as Core Axis for Glioma Cancer Stem-Like Cells Maintenance
    Antonio Lucena-Cacace et al, 2019, Front. Oncol. CrossRef
  6. Diagnostic biomarker and therapeutic target applications of miR‐326 in cancers: A systematic review
    Golamreza Jadideslam et al, 2019, J Cell Physiol CrossRef
  7. MicroRNA-33-3p Regulates Vein Endothelial Cell Apoptosis in Selenium-Deficient Broilers by Targeting E4F1
    Yiming Zhang et al, 2019, Oxidative Medicine and Cellular Longevity CrossRef
  8. Oxidative stress and cancer development: Are non-coding RNAs the missing links?
    Leonard Clinton D’Souza et al, 2019, Antioxidants & Redox Signaling CrossRef
  9. Litopenaeus vannamei sirtuin 6 (LvSIRT6) is involved in immune response by modulating hemocytes ROS production and apoptosis
    Junjie Nie et al, 2020, Fish & Shellfish Immunology CrossRef
  10. Long noncoding RNA HIF1A-AS2 facilitates cell survival and migration by sponging miR-33b-5p to modulate SIRT6 expression in osteosarcoma
    Hang Lin et al, 2019, Biochem. Cell Biol. CrossRef
  11. PD-L1 Inhibitor Regulates the miR-33a-5p/PTEN Signaling Pathway and Can Be Targeted to Sensitize Glioblastomas to Radiation
    Wenzheng Xia et al, 2020, Front. Oncol. CrossRef
  12. When Oxidative Stress Meets Epigenetics: Implications in Cancer Development
    Álvaro García-Guede et al, 2020, Antioxidants CrossRef
  13. Crosstalk between noncoding RNAs and ferroptosis: new dawn for overcoming cancer progression
    Xuefei Zhang et al, 2020, Cell Death Dis CrossRef
  14. Revisiting cancer hallmarks: insights from the interplay between oxidative stress and non-coding RNAs
    Li Zhou et al, 2020, Mol Biomed CrossRef
  15. Cross-talk between oxidative stress signaling and microRNA regulatory systems in carcinogenesis: Focused on gastrointestinal cancers
    Abolfazl Akbari et al, 2020, Biomedicine & Pharmacotherapy CrossRef

  16. Knockdown of circ-TTBK2 Inhibits Glioma Progression by Regulating miR-1283 and CHD1


    Chengchen Han et al, 2020, CMAR CrossRef
  17. SIRT6 promotes angiogenesis and hemorrhage of carotid plaque via regulating HIF-1α and reactive oxygen species.
    Zhou Yang et al, 2021, Cell Death Dis CrossRef
  18. The Two-Faced Role of SIRT6 in Cancer
    Francesco Fiorentino et al, 2021, Cancers CrossRef
  19. Long non-coding RNA LINC01003 suppresses the development of multiple myeloma by targeting miR-33a-5p/PIM1 axis
    Linlin Wu et al, 2021, Leukemia Research CrossRef
  20. miRNA-Mediated Oxidative Stress Management in Cancer
    Sourav Hom Choudhury et al, 2022 CrossRef
  21. SIRT6 Widely Regulates Aging, Immunity, and Cancer
    Yunjia Li et al, 2022, Front. Oncol. CrossRef
  22. Potential targets and treatments affect oxidative stress in gliomas: An overview of molecular mechanisms
    Shiyu Liu et al, 2022, Front. Pharmacol. CrossRef
  23. SIRT6 mediates multidimensional modulation to maintain organism homeostasis
    Yueying Yang et al, 2022, Journal Cellular Physiology CrossRef
  24. MiR-33a targets FOSL1 and EN2 as a clinical prognostic marker for sarcopenia by glioma
    Wei Wang et al, 2022, Front. Genet. CrossRef
  25. miRNA-Mediated Oxidative Stress Management in Cancer
    Sourav Hom Choudhury et al, 2022 CrossRef
  26. miR-33a inhibits cell growth in renal cancer by downregulation of MDM4 expression
    Kehua Jiang et al, 2019, Mol Genet Genomic Med CrossRef
  27. Constructing a signature based on the SIRT family to help the prognosis and treatment sensitivity in glioma patients
    Feiyue Xuan et al, 2022, Front. Genet. CrossRef
  28. Exploring the Multi-Faceted Role of Sirtuins in Glioblastoma Pathogenesis and Targeting Options
    Elena Kunadis et al, 2022, IJMS CrossRef
  29. Sirtuin 6 expression in colorectal adenocarcinoma
    DaliaN Abdelhafez et al, 2022, Egypt J Pathol CrossRef
  30. Effects of miR-33 Deficiency on Metabolic and Cardiovascular Diseases: Implications for Therapeutic Intervention
    Rebeca Ortega et al, 2023, IJMS CrossRef
  31. Noncoding RNAs in cancer ferroptosis: From biology to clinical opportunity
    Chan Shan et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  32. Preparation of polyclonal antibodies against the Drosophila deacetylases SIRT 6 and SIRT 7
    Zhenhao Wei et al, 2023, Protein Expression and Purification CrossRef
  33. The Role of Sirtuin 6 in the Deacetylation of Histone Proteins as a Factor in the Progression of Neoplastic Disease
    Marzena Baran et al, 2023, IJMS CrossRef
  34. Epigenetic Control of Redox Pathways in Cancer Progression
    Vandit Shah et al, 2025, Antioxidants & Redox Signaling CrossRef
  35. Revealing the Complex Interaction of Noncoding RNAs, Sirtuin Family, and Mitochondrial Function
    Ludong Yuan et al, 2025, The Journal of Gene Medicine CrossRef